SIMILAR PATTERNS OF AMINO ACIDS FOR 3G4L_A_ROFA901
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homo sapiens) |
PF00233(PDEase_I) | 5 | TYR A 736HIS A 737PRO A 941SER A 990PHE A 991 | IBM A2111 (-4.5A)IBM A2111 ( 4.8A)NoneNoneIBM A2111 (-3.6A) | 1.25A | 3g4lA-1sojA:42.0 | 3g4lA-1sojA:32.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homo sapiens) |
PF00233(PDEase_I) | 7 | TYR A 736HIS A 737PRO A 941TRP A 951THR A 952ILE A 955PHE A 991 | IBM A2111 (-4.5A)IBM A2111 ( 4.8A)NoneNoneIBM A2111 ( 4.8A)IBM A2111 (-4.2A)IBM A2111 (-3.6A) | 0.53A | 3g4lA-1sojA:42.0 | 3g4lA-1sojA:32.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1xkh | FERRIPYOVERDINERECEPTOR (Pseudomonasaeruginosa) |
PF00593(TonB_dep_Rec)PF07715(Plug) | 5 | HIS A 324ASN A 384PRO A 367SER A 440PHE A 503 | None | 1.33A | 3g4lA-1xkhA:undetectable | 3g4lA-1xkhA:19.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1zkl | HIGH-AFFINITYCAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 7A (Homo sapiens) |
PF00233(PDEase_I) | 6 | TYR A 211HIS A 212ASN A 365PRO A 366TRP A 376PHE A 416 | IBM A 503 (-4.6A)NoneIBM A 503 ( 4.7A)NoneNoneIBM A 503 (-3.4A) | 0.42A | 3g4lA-1zklA:45.4 | 3g4lA-1zklA:33.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1znp | HYPOTHETICAL PROTEINATU3615 (Agrobacteriumfabrum) |
PF06172(Cupin_5) | 5 | TYR A 25HIS A 19THR A 28ILE A 43SER A 40 | None | 1.31A | 3g4lA-1znpA:undetectable | 3g4lA-1znpA:16.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2qyk | CYCLIC AMP-SPECIFICPHOSPHODIESTERASEHSPDE4A10 (Homo sapiens) |
PF00233(PDEase_I) | 12 | TYR A 371HIS A 372MET A 485ASN A 533PRO A 534TYR A 541TRP A 544THR A 545ILE A 548MET A 569SER A 580PHE A 584 | NPV A 3 (-4.4A)NPV A 3 (-4.6A)NoneNPV A 3 (-4.4A)NoneNoneNoneNPV A 3 ( 4.7A)NPV A 3 (-3.8A)NPV A 3 (-3.1A)NPV A 3 (-4.5A)NPV A 3 (-3.3A) | 0.49A | 3g4lA-2qykA:51.8 | 3g4lA-2qykA:85.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2qym | PHOSPHODIESTERASE 4C (Homo sapiens) |
PF00233(PDEase_I) | 9 | TYR A 281HIS A 282MET A 395ASN A 443PRO A 444TRP A 454THR A 455ILE A 458PHE A 494 | None | 0.59A | 3g4lA-2qymA:43.1 | 3g4lA-2qymA:83.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2qym | PHOSPHODIESTERASE 4C (Homo sapiens) |
PF00233(PDEase_I) | 9 | TYR A 281HIS A 282MET A 395ASN A 443PRO A 444TYR A 451TRP A 454THR A 455PHE A 494 | None | 0.60A | 3g4lA-2qymA:43.1 | 3g4lA-2qymA:83.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2r8q | CLASS IPHOSPHODIESTERASEPDEB1 (Leishmaniamajor) |
PF00233(PDEase_I) | 6 | TYR A 680HIS A 681MET A 797ASN A 838TRP A 849PHE A 890 | IBM A 3 ( 4.7A)IBM A 3 ( 4.8A)NoneIBM A 3 (-4.5A)NoneIBM A 3 (-3.6A) | 0.40A | 3g4lA-2r8qA:38.8 | 3g4lA-2r8qA:29.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ecn | HIGH AFFINITYCAMP-SPECIFIC ANDIBMX-INSENSITIVE3',5'-CYCLICPHOSPHODIESTERASE 8A (Homo sapiens) |
PF00233(PDEase_I) | 5 | MET A 670ASN A 729PRO A 730SER A 780PHE A 781 | IBM A 3 (-4.5A)NoneNoneNoneIBM A 3 (-3.5A) | 1.01A | 3g4lA-3ecnA:44.8 | 3g4lA-3ecnA:32.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ecn | HIGH AFFINITYCAMP-SPECIFIC ANDIBMX-INSENSITIVE3',5'-CYCLICPHOSPHODIESTERASE 8A (Homo sapiens) |
PF00233(PDEase_I) | 9 | TYR A 555HIS A 556MET A 670ASN A 729PRO A 730TRP A 740ILE A 744SER A 777PHE A 781 | NoneNoneIBM A 3 (-4.5A)NoneNoneNoneIBM A 3 (-4.3A)NoneIBM A 3 (-3.5A) | 0.43A | 3g4lA-3ecnA:44.8 | 3g4lA-3ecnA:32.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3g4g | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homo sapiens) |
PF00233(PDEase_I) | 5 | HIS A 326MET A 439MET A 523SER A 534PHE A 538 | D71 A 901 (-4.5A)D71 A 901 ( 4.0A)D71 A 901 ( 4.0A)D71 A 901 (-3.4A)D71 A 901 (-3.9A) | 1.03A | 3g4lA-3g4gA:52.5 | 3g4lA-3g4gA:74.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3g4g | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homo sapiens) |
PF00233(PDEase_I) | 11 | TYR A 325HIS A 326MET A 439ASN A 487PRO A 488TYR A 495TRP A 498THR A 499ILE A 502MET A 523PHE A 538 | NoneD71 A 901 (-4.5A)D71 A 901 ( 4.0A)D71 A 901 (-4.5A)NoneNoneNoneD71 A 901 (-3.6A)D71 A 901 (-4.1A)D71 A 901 ( 4.0A)D71 A 901 (-3.9A) | 0.61A | 3g4lA-3g4gA:52.5 | 3g4lA-3g4gA:74.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3o57 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B (Homo sapiens) |
PF00233(PDEase_I) | 12 | TYR A 233HIS A 234MET A 347ASN A 395PRO A 396TYR A 403TRP A 406THR A 407ILE A 410MET A 431SER A 442PHE A 446 | NoneNoneZG2 A 506 (-3.9A)ZG2 A 506 (-4.3A)ZG2 A 506 ( 4.5A)NoneNoneZG2 A 506 (-4.3A)ZG2 A 506 (-4.4A)ZG2 A 506 (-3.4A)NoneZG2 A 506 (-3.6A) | 0.53A | 3g4lA-3o57A:51.6 | 3g4lA-3o57A:80.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3qi3 | HIGH AFFINITYCGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 9A (Homo sapiens) |
PF00233(PDEase_I) | 5 | HIS A 252MET A 365ASN A 405TRP A 416PHE A 456 | PDB A 600 (-4.6A)PDB A 600 ( 4.7A)PDB A 600 (-4.4A)NonePDB A 600 (-3.5A) | 0.58A | 3g4lA-3qi3A:41.8 | 3g4lA-3qi3A:24.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3rko | NADH-QUINONEOXIDOREDUCTASESUBUNIT L (Escherichiacoli) |
no annotation | 5 | MET L 432TYR L 102ILE L 353MET L 243SER L 250 | None | 1.37A | 3g4lA-3rkoL:undetectable | 3g4lA-3rkoL:21.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3sl5 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homo sapiens) |
PF00233(PDEase_I) | 10 | TYR A 159HIS A 160ASN A 321PRO A 322TYR A 329TRP A 332THR A 333ILE A 336MET A 357SER A 368 | TYR A 159 (-1.3A)HIS A 160 ( 1.0A)ASN A 321 (-0.6A)PRO A 322 (-1.1A)TYR A 329 (-1.3A)TRP A 332 ( 0.5A)THR A 333 ( 0.8A)ILE A 336 ( 0.4A)MET A 357 (-0.0A)SER A 368 (-0.0A) | 0.52A | 3g4lA-3sl5A:53.4 | 3g4lA-3sl5A:98.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3sl5 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homo sapiens) |
PF00233(PDEase_I) | 11 | TYR A 159HIS A 160MET A 273ASN A 321PRO A 322TYR A 329TRP A 332THR A 333ILE A 336SER A 368PHE A 372 | TYR A 159 (-1.3A)HIS A 160 ( 1.0A)MET A 273 (-0.0A)ASN A 321 (-0.6A)PRO A 322 (-1.1A)TYR A 329 (-1.3A)TRP A 332 ( 0.5A)THR A 333 ( 0.8A)ILE A 336 ( 0.4A)SER A 368 (-0.0A)PHE A 372 (-1.3A) | 0.44A | 3g4lA-3sl5A:53.4 | 3g4lA-3sl5A:98.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3v94 | CYCLIC NUCLEOTIDESPECIFICPHOSPHODIESTERASE (Trypanosomacruzi) |
PF00233(PDEase_I) | 6 | TYR A 367HIS A 368MET A 482TRP A 535ILE A 538PHE A 573 | WYQ A 701 (-4.5A)NoneWYQ A 701 (-4.5A)NoneWYQ A 701 ( 4.1A)WYQ A 701 (-3.4A) | 0.75A | 3g4lA-3v94A:39.7 | 3g4lA-3v94A:30.28 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4i15 | CLASS 1PHOSPHODIESTERASEPDEB1 (Trypanosomabrucei) |
PF00233(PDEase_I) | 6 | TYR A 668HIS A 669MET A 785ASN A 825TRP A 836PHE A 877 | None | 0.44A | 3g4lA-4i15A:38.2 | 3g4lA-4i15A:32.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4udj | UHGB_MP (unculturedorganism) |
PF04041(Glyco_hydro_130) | 5 | TYR A 300ASN A 28PRO A 29THR A 307SER A 41 | NoneNonePGE A 608 (-3.8A)None K A 606 (-2.6A) | 1.27A | 3g4lA-4udjA:undetectable | 3g4lA-4udjA:19.37 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4wzi | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B (Homo sapiens) |
PF00233(PDEase_I) | 11 | TYR A 405HIS A 406MET A 519ASN A 567PRO A 568TRP A 578THR A 579ILE A 582MET A 603SER A 614PHE A 618 | None MG A 804 ( 4.9A)NoneNoneNoneNoneNoneNoneNoneNoneNone | 0.74A | 3g4lA-4wziA:52.2 | 3g4lA-4wziA:47.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4wzi | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B (Homo sapiens) |
PF00233(PDEase_I) | 11 | TYR A 405HIS A 406MET A 519ASN A 567PRO A 568TYR A 575TRP A 578THR A 579MET A 603SER A 614PHE A 618 | None MG A 804 ( 4.9A)NoneNoneNoneNoneNoneNoneNoneNoneNone | 0.60A | 3g4lA-4wziA:52.2 | 3g4lA-4wziA:47.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4z81 | EGF FAMILYDOMAIN-CONTAININGPROTEIN (Toxoplasmagondii) |
PF02430(AMA-1)PF07974(EGF_2) | 5 | ASN A 171THR A 167MET A 373SER A 164PHE A 156 | None | 1.47A | 3g4lA-4z81A:undetectable | 3g4lA-4z81A:20.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5b25 | CALCIUM/CALMODULIN-DEPENDENT3',5'-CYCLICNUCLEOTIDEPHOSPHODIESTERASE 1B (Homo sapiens) |
PF00233(PDEase_I) | 8 | TYR A 222HIS A 223MET A 336PRO A 374TRP A 384THR A 385SER A 420PHE A 424 | None4QJ A 603 ( 4.9A)4QJ A 603 ( 3.9A)NoneNoneNone4QJ A 603 (-4.7A)4QJ A 603 (-3.5A) | 0.43A | 3g4lA-5b25A:43.8 | 3g4lA-5b25A:37.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5h2r | PHOSPHODIESTERASE (Trypanosomabrucei) |
no annotation | 5 | MET A 785ASN A 826TRP A 837MET A 862PHE A 878 | LLN A1003 (-4.0A)LLN A1003 (-4.4A)NoneLLN A1003 (-3.5A)LLN A1003 (-3.8A) | 0.98A | 3g4lA-5h2rA:38.8 | 3g4lA-5h2rA:31.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5h2r | PHOSPHODIESTERASE (Trypanosomabrucei) |
no annotation | 6 | TYR A 668HIS A 669MET A 785ASN A 826TRP A 837PHE A 878 | LLN A1003 ( 4.8A)NoneLLN A1003 (-4.0A)LLN A1003 (-4.4A)NoneLLN A1003 (-3.8A) | 0.34A | 3g4lA-5h2rA:38.8 | 3g4lA-5h2rA:31.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ohj | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B (Homo sapiens) |
no annotation | 9 | TYR A 405ASN A 567PRO A 568TYR A 575TRP A 578THR A 579ILE A 582MET A 603PHE A 618 | None9VE A 801 (-4.1A)9VE A 801 (-3.9A)9VE A 801 (-4.6A)None9VE A 801 (-4.1A)9VE A 801 (-4.1A)9VE A 801 (-3.6A)9VE A 801 (-3.9A) | 0.68A | 3g4lA-5ohjA:51.7 | 3g4lA-5ohjA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ohj | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B (Homo sapiens) |
no annotation | 11 | TYR A 405HIS A 406MET A 519ASN A 567PRO A 568TYR A 575TRP A 578THR A 579ILE A 582SER A 614PHE A 618 | NoneNone9VE A 801 (-3.8A)9VE A 801 (-4.1A)9VE A 801 (-3.9A)9VE A 801 (-4.6A)None9VE A 801 (-4.1A)9VE A 801 (-4.1A)9VE A 801 (-4.7A)9VE A 801 (-3.9A) | 0.27A | 3g4lA-5ohjA:51.7 | 3g4lA-5ohjA:undetectable | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5vyd | PHOSPHODIESTERASE (Salpingoecarosetta) |
no annotation | 5 | HIS A 83MET A 195ASN A 239PRO A 240PHE A 291 | None | 0.71A | 3g4lA-5vydA:39.6 | 3g4lA-5vydA:30.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5wh6 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homo sapiens) |
no annotation | 11 | TYR A 159HIS A 160MET A 273ASN A 321PRO A 322TYR A 329TRP A 332THR A 333ILE A 336MET A 357PHE A 372 | AKJ A 601 ( 4.7A)NoneAKJ A 601 ( 3.9A)AKJ A 601 (-4.3A)AKJ A 601 (-3.9A)AKJ A 601 (-4.8A)NoneAKJ A 601 (-4.1A)AKJ A 601 (-3.8A)AKJ A 601 (-3.4A)AKJ A 601 (-4.1A) | 0.42A | 3g4lA-5wh6A:54.2 | 3g4lA-5wh6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5wh6 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homo sapiens) |
no annotation | 9 | TYR A 159HIS A 160PRO A 322TYR A 329TRP A 332THR A 333ILE A 336MET A 357SER A 368 | AKJ A 601 ( 4.7A)NoneAKJ A 601 (-3.9A)AKJ A 601 (-4.8A)NoneAKJ A 601 (-4.1A)AKJ A 601 (-3.8A)AKJ A 601 (-3.4A)AKJ A 601 (-2.5A) | 0.66A | 3g4lA-5wh6A:54.2 | 3g4lA-5wh6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xjh | POLY(ETHYLENETEREPHTHALATE)HYDROLASE (Ideonellasakaiensis) |
no annotation | 5 | PRO A 99TYR A 69THR A 110ILE A 83SER A 92 | None | 1.08A | 3g4lA-5xjhA:undetectable | 3g4lA-5xjhA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xjh | POLY(ETHYLENETEREPHTHALATE)HYDROLASE (Ideonellasakaiensis) |
no annotation | 5 | PRO A 99TYR A 69THR A 110ILE A 83SER A 93 | None | 1.30A | 3g4lA-5xjhA:undetectable | 3g4lA-5xjhA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5yfb | DIPEPTIDYL PEPTIDASE3 (Armillariatabescens) |
no annotation | 5 | TYR A 276HIS A 288ILE A 307SER A 375PHE A 326 | None | 1.11A | 3g4lA-5yfbA:undetectable | 3g4lA-5yfbA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6ane | POLY(ETHYLENETEREPHTHALATE)HYDROLASE (Ideonellasakaiensis) |
no annotation | 5 | PRO A 72TYR A 42THR A 83ILE A 56SER A 65 | None | 1.06A | 3g4lA-6aneA:undetectable | 3g4lA-6aneA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6ane | POLY(ETHYLENETEREPHTHALATE)HYDROLASE (Ideonellasakaiensis) |
no annotation | 5 | PRO A 72TYR A 42THR A 83ILE A 56SER A 66 | None | 1.31A | 3g4lA-6aneA:undetectable | 3g4lA-6aneA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1dcq | PYK2-ASSOCIATEDPROTEIN BETA (Mus musculus) |
PF01412(ArfGap)PF12796(Ank_2) | 3 | ASP A 307LEU A 309GLN A 437 | None | 0.71A | 3g4lA-1dcqA:undetectable | 3g4lA-1dcqA:22.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1eak | 72 KDA TYPE IVCOLLAGENASE (Homo sapiens) |
PF00040(fn2)PF00413(Peptidase_M10)PF01471(PG_binding_1) | 3 | ASP A 249LEU A 257GLN A 219 | None | 0.82A | 3g4lA-1eakA:undetectable | 3g4lA-1eakA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ezv | UBIQUINOL-CYTOCHROMEC REDUCTASE COMPLEXCORE PROTEIN I (Saccharomycescerevisiae) |
PF00675(Peptidase_M16)PF05193(Peptidase_M16_C) | 3 | ASP A 191LEU A 192GLN A 101 | None | 0.74A | 3g4lA-1ezvA:undetectable | 3g4lA-1ezvA:21.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1g8k | ARSENITE OXIDASEARSENITE OXIDASE (Alcaligenesfaecalis;Alcaligenesfaecalis) |
PF00384(Molybdopterin)PF01568(Molydop_binding)PF00355(Rieske) | 3 | ASP A 5LEU B 124GLN A 57 | None | 0.70A | 3g4lA-1g8kA:undetectable | 3g4lA-1g8kA:18.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1gl2 | SYNTAXIN 7VESICLE TRANSPORTV-SNARE PROTEINVTI1-LIKE 1 (Mus musculus;Mus musculus) |
PF05739(SNARE)PF12352(V-SNARE_C) | 3 | ASP B 191LEU B 192GLN C 170 | None | 0.73A | 3g4lA-1gl2B:undetectable | 3g4lA-1gl2B:11.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ii0 | ARSENICALPUMP-DRIVING ATPASE (Escherichiacoli) |
PF02374(ArsA_ATPase) | 3 | ASP A 417LEU A 418GLN A 430 | None | 0.69A | 3g4lA-1ii0A:undetectable | 3g4lA-1ii0A:22.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1jog | HYPOTHETICAL PROTEINHI0074 (Haemophilusinfluenzae) |
PF08780(NTase_sub_bind) | 3 | ASP A 12LEU A 11GLN A 64 | None | 0.83A | 3g4lA-1jogA:undetectable | 3g4lA-1jogA:18.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1moe | ANTI-CEA MAB T84.66 (Mus musculus) |
PF07686(V-set) | 3 | ASP A 86LEU A 108GLN A 6 | None | 0.80A | 3g4lA-1moeA:undetectable | 3g4lA-1moeA:19.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1qfx | PROTEIN (PH 2.5 ACIDPHOSPHATASE) (Aspergillusniger) |
PF00328(His_Phos_2) | 3 | ASP A 191LEU A 432GLN A 304 | NoneNAG A 596 (-4.7A)GOL A 703 (-4.0A) | 0.62A | 3g4lA-1qfxA:undetectable | 3g4lA-1qfxA:21.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1qgr | PROTEIN (IMPORTINBETA SUBUNIT) (Homo sapiens) |
PF03810(IBN_N)PF13513(HEAT_EZ) | 3 | ASP A 579LEU A 583GLN A 589 | None | 0.78A | 3g4lA-1qgrA:undetectable | 3g4lA-1qgrA:19.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1qnz | 0.5B ANTIBODY (LIGHTCHAIN) (Mus musculus) |
PF07686(V-set) | 3 | ASP L 86LEU L 108GLN L 6 | None | 0.66A | 3g4lA-1qnzL:undetectable | 3g4lA-1qnzL:14.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1qqf | PROTEIN (COMPLEMENTC3DG) (Rattusnorvegicus) |
PF07678(A2M_comp)PF10569(Thiol-ester_cl) | 3 | ASP A1140LEU A1143GLN A1127 | None | 0.77A | 3g4lA-1qqfA:undetectable | 3g4lA-1qqfA:22.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1tzs | CATHEPSIN E (Homo sapiens) |
PF00026(Asp) | 3 | ASP A 290LEU A 288GLN A 245 | None | 0.67A | 3g4lA-1tzsA:undetectable | 3g4lA-1tzsA:21.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1uio | ADENOSINE DEAMINASE (Mus musculus) |
PF00962(A_deaminase) | 3 | ASP A 128LEU A 132GLN A 138 | None | 0.80A | 3g4lA-1uioA:undetectable | 3g4lA-1uioA:20.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1x9s | DNA POLYMERASE (Escherichiavirus T7) |
PF00476(DNA_pol_A) | 3 | ASP A 65LEU A 69GLN A 76 | MG A3001 ( 4.0A)NoneNone | 0.81A | 3g4lA-1x9sA:undetectable | 3g4lA-1x9sA:19.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2a0l | 33H1 FV FRAGMENT (Mus musculus) |
PF07686(V-set) | 3 | ASP C 83LEU C 104GLN C 6 | None | 0.82A | 3g4lA-2a0lC:undetectable | 3g4lA-2a0lC:14.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2bi0 | HYPOTHETICAL PROTEINRV0216 (Mycobacteriumtuberculosis) |
no annotation | 3 | ASP A 329LEU A 328GLN A 260 | None | 0.80A | 3g4lA-2bi0A:undetectable | 3g4lA-2bi0A:21.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2c27 | MYCOTHIOL SYNTHASE (Mycobacteriumtuberculosis) |
PF00583(Acetyltransf_1) | 3 | ASP A 163LEU A 167GLN A 180 | None | 0.72A | 3g4lA-2c27A:undetectable | 3g4lA-2c27A:23.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2coc | FYVE, RHOGEF AND PHDOMAIN CONTAININGPROTEIN 3 (Homo sapiens) |
no annotation | 3 | ASP A 46LEU A 49GLN A 82 | None | 0.76A | 3g4lA-2cocA:undetectable | 3g4lA-2cocA:15.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2hg4 | 6-DEOXYERYTHRONOLIDEB SYNTHASE (Saccharopolysporaerythraea) |
PF00109(ketoacyl-synt)PF00698(Acyl_transf_1)PF02801(Ketoacyl-synt_C)PF08990(Docking)PF16197(KAsynt_C_assoc) | 3 | ASP A 722LEU A 721GLN A 748 | None | 0.77A | 3g4lA-2hg4A:undetectable | 3g4lA-2hg4A:16.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2i3o | GAMMA-GLUTAMYLTRANSFERASE RELATEDPROTEIN (Thermoplasmaacidophilum) |
PF01019(G_glu_transpept) | 3 | ASP A 330LEU A 54GLN A 490 | None | 0.72A | 3g4lA-2i3oA:undetectable | 3g4lA-2i3oA:21.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2inf | UROPORPHYRINOGENDECARBOXYLASE (Bacillussubtilis) |
PF01208(URO-D) | 3 | ASP A 266LEU A 265GLN A 309 | None | 0.83A | 3g4lA-2infA:undetectable | 3g4lA-2infA:22.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2iya | OLEANDOMYCINGLYCOSYLTRANSFERASE (Streptomycesantibioticus) |
PF00201(UDPGT) | 3 | ASP A 317LEU A 316GLN A 34 | None | 0.63A | 3g4lA-2iyaA:undetectable | 3g4lA-2iyaA:22.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2jft | SER-THR PHOSPHATASEMSPP (Mycolicibacteriumsmegmatis) |
PF13672(PP2C_2) | 3 | ASP A 27LEU A 30GLN A 101 | None | 0.68A | 3g4lA-2jftA:undetectable | 3g4lA-2jftA:21.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2jg2 | SERINEPALMITOYLTRANSFERASE (Sphingomonaspaucimobilis) |
PF00155(Aminotran_1_2) | 3 | ASP A 155LEU A 201GLN A 250 | None | 0.77A | 3g4lA-2jg2A:undetectable | 3g4lA-2jg2A:21.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2m7a | UNCHARACTERIZEDPROTEIN (Escherichiacoli) |
no annotation | 3 | ASP A 42LEU A 30GLN A 18 | None | 0.74A | 3g4lA-2m7aA:undetectable | 3g4lA-2m7aA:14.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2oew | PROGRAMMED CELLDEATH 6-INTERACTINGPROTEIN (Homo sapiens) |
PF03097(BRO1) | 3 | ASP A 59LEU A 58GLN A 8 | None | 0.81A | 3g4lA-2oewA:undetectable | 3g4lA-2oewA:21.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2pff | FATTY ACID SYNTHASESUBUNIT ALPHA (Saccharomycescerevisiae) |
PF00106(adh_short)PF00109(ketoacyl-synt)PF02801(Ketoacyl-synt_C) | 3 | ASP A 925LEU A 926GLN A 898 | None | 0.84A | 3g4lA-2pffA:undetectable | 3g4lA-2pffA:11.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2pk2 | CYCLIN-T1, PROTEINTAT (Homo sapiens;Equineinfectiousanemia virus) |
PF00134(Cyclin_N) | 3 | ASP A 32LEU A 35GLN A 190 | ASP A 32 ( 0.6A)LEU A 35 ( 0.6A)GLN A 190 ( 0.6A) | 0.59A | 3g4lA-2pk2A:undetectable | 3g4lA-2pk2A:21.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2qr6 | IMPDEHYDROGENASE/GMPREDUCTASE (Corynebacteriumglutamicum) |
PF00478(IMPDH) | 3 | ASP A 252LEU A 251GLN A 367 | None | 0.80A | 3g4lA-2qr6A:undetectable | 3g4lA-2qr6A:19.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2qyk | CYCLIC AMP-SPECIFICPHOSPHODIESTERASEHSPDE4A10 (Homo sapiens) |
PF00233(PDEase_I) | 3 | ASP A 530LEU A 531GLN A 581 | ZN A 1 (-2.5A)NoneNPV A 3 (-3.1A) | 0.35A | 3g4lA-2qykA:51.8 | 3g4lA-2qykA:85.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2qym | PHOSPHODIESTERASE 4C (Homo sapiens) |
PF00233(PDEase_I) | 3 | ASP A 220LEU A 226GLN A 453 | None | 0.79A | 3g4lA-2qymA:43.1 | 3g4lA-2qymA:83.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2uv8 | FATTY ACID SYNTHASESUBUNIT BETA (FAS1) (Saccharomycescerevisiae) |
PF00698(Acyl_transf_1)PF01575(MaoC_dehydratas)PF08354(DUF1729)PF13452(MaoC_dehydrat_N)PF16073(SAT) | 3 | ASP G1791LEU G1792GLN G1659 | None | 0.82A | 3g4lA-2uv8G:undetectable | 3g4lA-2uv8G:10.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2woc | ADP-RIBOSYL-[DINITROGEN REDUCTASE]GLYCOHYDROLASE (Rhodospirillumrubrum) |
PF03747(ADP_ribosyl_GH) | 3 | ASP A 21LEU A 17GLN A 283 | None | 0.63A | 3g4lA-2wocA:undetectable | 3g4lA-2wocA:18.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2wrg | HEMAGGLUTININ HA2CHAIN (Influenza Avirus) |
PF00509(Hemagglutinin) | 3 | ASP I 586LEU I 589GLN I 562 | None | 0.83A | 3g4lA-2wrgI:undetectable | 3g4lA-2wrgI:19.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xn1 | ALPHA-GALACTOSIDASE (Lactobacillusacidophilus) |
PF02065(Melibiase)PF16874(Glyco_hydro_36C)PF16875(Glyco_hydro_36N) | 3 | ASP A 56LEU A 55GLN A 272 | None | 0.83A | 3g4lA-2xn1A:undetectable | 3g4lA-2xn1A:19.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xr1 | CLEAVAGE ANDPOLYADENYLATIONSPECIFICITY FACTOR100 KD SUBUNIT (Methanosarcinamazei) |
PF07521(RMMBL)PF07650(KH_2)PF10996(Beta-Casp)PF16661(Lactamase_B_6)PF17214(KH_7) | 3 | ASP A 279LEU A 275GLN A 422 | None | 0.74A | 3g4lA-2xr1A:undetectable | 3g4lA-2xr1A:20.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xub | DNA-DIRECTED RNAPOLYMERASE IIISUBUNIT RPC3 (Homo sapiens) |
PF05645(RNA_pol_Rpc82)PF08221(HTH_9) | 3 | ASP A 318LEU A 320GLN A 371 | None | 0.79A | 3g4lA-2xubA:undetectable | 3g4lA-2xubA:21.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ycb | CLEAVAGE ANDPOLYADENYLATIONSPECIFICITY FACTOR (Methanothermobacterthermautotrophicus) |
PF07521(RMMBL)PF10996(Beta-Casp)PF16661(Lactamase_B_6)PF17214(KH_7) | 3 | ASP A 279LEU A 275GLN A 422 | None | 0.79A | 3g4lA-2ycbA:undetectable | 3g4lA-2ycbA:20.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2zqq | METHYLGLUTACONYL-COAHYDRATASE (Homo sapiens) |
PF00378(ECH_1) | 3 | ASP A 273LEU A 274GLN A 281 | None | 0.80A | 3g4lA-2zqqA:undetectable | 3g4lA-2zqqA:24.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3b2r | CGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE (Homo sapiens) |
PF00233(PDEase_I) | 3 | ASP A 764LEU A 765GLN A 775 | NoneVDN A 1 ( 4.7A)VDN A 1 ( 4.4A) | 0.68A | 3g4lA-3b2rA:31.3 | 3g4lA-3b2rA:27.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3b2r | CGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE (Homo sapiens) |
PF00233(PDEase_I) | 3 | ASP A 764LEU A 765GLN A 817 | NoneVDN A 1 ( 4.7A)VDN A 1 (-3.0A) | 0.50A | 3g4lA-3b2rA:31.3 | 3g4lA-3b2rA:27.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3beo | UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE (Bacillusanthracis) |
PF02350(Epimerase_2) | 3 | ASP A 49LEU A 48GLN A 70 | NoneNoneUD1 A 372 (-3.7A) | 0.73A | 3g4lA-3beoA:undetectable | 3g4lA-3beoA:23.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3bga | BETA-GALACTOSIDASE (Bacteroidesthetaiotaomicron) |
PF00703(Glyco_hydro_2)PF02836(Glyco_hydro_2_C)PF02837(Glyco_hydro_2_N)PF02929(Bgal_small_N)PF16353(DUF4981) | 3 | ASP A 452LEU A 449GLN A 189 | None | 0.78A | 3g4lA-3bgaA:undetectable | 3g4lA-3bgaA:17.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3bjc | CGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE (Homo sapiens) |
PF00233(PDEase_I) | 3 | ASP A 764LEU A 765GLN A 775 | ZN A 876 (-2.5A)WAN A 901 ( 4.7A)WAN A 901 ( 4.6A) | 0.61A | 3g4lA-3bjcA:34.1 | 3g4lA-3bjcA:19.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3bjc | CGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE (Homo sapiens) |
PF00233(PDEase_I) | 3 | ASP A 764LEU A 765GLN A 817 | ZN A 876 (-2.5A)WAN A 901 ( 4.7A)WAN A 901 (-3.1A) | 0.48A | 3g4lA-3bjcA:34.1 | 3g4lA-3bjcA:19.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ciy | TOLL-LIKE RECEPTOR 3 (Mus musculus) |
PF00560(LRR_1)PF13855(LRR_8) | 3 | ASP A 203LEU A 177GLN A 107 | None | 0.79A | 3g4lA-3ciyA:undetectable | 3g4lA-3ciyA:20.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3d3a | BETA-GALACTOSIDASE (Bacteroidesthetaiotaomicron) |
PF01301(Glyco_hydro_35) | 3 | ASP A 462LEU A 464GLN A 400 | None | 0.83A | 3g4lA-3d3aA:undetectable | 3g4lA-3d3aA:21.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3dec | BETA-GALACTOSIDASE (Bacteroidesthetaiotaomicron) |
PF00703(Glyco_hydro_2)PF02836(Glyco_hydro_2_C)PF02837(Glyco_hydro_2_N)PF02929(Bgal_small_N)PF16353(DUF4981) | 3 | ASP A 428LEU A 425GLN A 165 | None | 0.77A | 3g4lA-3decA:undetectable | 3g4lA-3decA:17.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3dwm | 9.5 KDA CULTUREFILTRATE ANTIGENCFP10A (Mycobacteriumtuberculosis) |
PF02597(ThiS) | 3 | ASP A 34LEU A 35GLN A 18 | None | 0.66A | 3g4lA-3dwmA:undetectable | 3g4lA-3dwmA:16.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3e02 | UNCHARACTERIZEDPROTEIN DUF849 (Paraburkholderiaxenovorans) |
PF05853(BKACE) | 3 | ASP A 63LEU A 66GLN A 73 | None | 0.76A | 3g4lA-3e02A:undetectable | 3g4lA-3e02A:20.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3f1i | HEPATOCYTE GROWTHFACTOR-REGULATEDTYROSINE KINASESUBSTRATE (Homo sapiens) |
PF12210(Hrs_helical) | 3 | ASP H 461LEU H 465GLN H 471 | None | 0.67A | 3g4lA-3f1iH:undetectable | 3g4lA-3f1iH:15.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3g4g | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homo sapiens) |
PF00233(PDEase_I) | 3 | ASP A 484LEU A 485GLN A 535 | ZN A 801 (-2.6A)NoneD71 A 901 (-3.1A) | 0.29A | 3g4lA-3g4gA:52.5 | 3g4lA-3g4gA:74.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3g6i | PUTATIVE OUTERMEMBRANE PROTEIN,PART OF CARBOHYDRATEBINDING COMPLEX (Bacteroidesthetaiotaomicron) |
PF12875(DUF3826) | 3 | ASP A 51LEU A 49GLN A 41 | None | 0.80A | 3g4lA-3g6iA:undetectable | 3g4lA-3g6iA:18.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3hjv | MALONYL COA-ACYLCARRIER PROTEINTRANSACYLASE (Vibrio cholerae) |
PF00698(Acyl_transf_1) | 3 | ASP A 26LEU A 27GLN A 84 | SO4 A 319 (-4.9A)NoneSO4 A 323 (-3.4A) | 0.81A | 3g4lA-3hjvA:undetectable | 3g4lA-3hjvA:23.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3iy5 | ANTIBODY FRAGMENTIGG2A (LIGHT CHAIN) (Mus musculus) |
PF07686(V-set) | 3 | ASP A 83LEU A 105GLN A 6 | None | 0.80A | 3g4lA-3iy5A:undetectable | 3g4lA-3iy5A:14.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3j1e | CHAPERONIN BETASUBUNIT (Acidianustengchongensis) |
PF00118(Cpn60_TCP1) | 3 | ASP A 157LEU A 160GLN A 499 | None | 0.59A | 3g4lA-3j1eA:undetectable | 3g4lA-3j1eA:22.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3jau | HEAVY CHAIN OF FABFRAGMENT VARIABLEREGION OF ANTIBODYD5 (Mus musculus) |
PF07686(V-set) | 3 | ASP H 90LEU H 114GLN H 6 | None | 0.81A | 3g4lA-3jauH:undetectable | 3g4lA-3jauH:14.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3mil | ISOAMYLACETATE-HYDROLYZINGESTERASE (Saccharomycescerevisiae) |
PF13472(Lipase_GDSL_2) | 3 | ASP A 125LEU A 185GLN A 29 | None | 0.83A | 3g4lA-3milA:undetectable | 3g4lA-3milA:18.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3o57 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B (Homo sapiens) |
PF00233(PDEase_I) | 3 | ASP A 392LEU A 393GLN A 443 | ZN A 1 (-2.6A)NoneZG2 A 506 (-3.3A) | 0.27A | 3g4lA-3o57A:51.6 | 3g4lA-3o57A:80.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ohm | 1-PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATEPHOSPHODIESTERASEBETA-3 (Homo sapiens) |
PF00168(C2)PF00387(PI-PLC-Y)PF00388(PI-PLC-X)PF09279(EF-hand_like) | 3 | ASP B 227LEU B 231GLN B 245 | None | 0.80A | 3g4lA-3ohmB:undetectable | 3g4lA-3ohmB:17.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3omb | EXTRACELLULARSOLUTE-BINDINGPROTEIN, FAMILY 1 (Bifidobacteriumlongum) |
PF01547(SBP_bac_1) | 3 | ASP A 153LEU A 421GLN A 51 | None | 0.81A | 3g4lA-3ombA:undetectable | 3g4lA-3ombA:21.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3one | ADENOSYLHOMOCYSTEINASE (Lupinus luteus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 3 | ASP A 142LEU A 145GLN A 215 | None | 0.75A | 3g4lA-3oneA:undetectable | 3g4lA-3oneA:20.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3r5e | TRANSALDOLASE (Corynebacteriumglutamicum) |
PF00923(TAL_FSA) | 3 | ASP A 118LEU A 121GLN A 184 | None | 0.83A | 3g4lA-3r5eA:undetectable | 3g4lA-3r5eA:20.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3rhg | PUTATIVEPHOPHOTRIESTERASE (Proteusmirabilis) |
PF02126(PTE) | 3 | ASP A 294LEU A 257GLN A 55 | CAC A 370 (-2.4A)NoneNone | 0.79A | 3g4lA-3rhgA:undetectable | 3g4lA-3rhgA:21.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) |
PF00104(Hormone_recep) | 3 | ASP A 60LEU A 64GLN A 230 | None | 0.80A | 3g4lA-3ry9A:undetectable | 3g4lA-3ry9A:19.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3sl5 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homo sapiens) |
PF00233(PDEase_I) | 3 | ASP A 318LEU A 319GLN A 369 | ASP A 318 (-0.5A)LEU A 319 ( 0.6A)GLN A 369 (-0.6A) | 0.34A | 3g4lA-3sl5A:53.4 | 3g4lA-3sl5A:98.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3t8l | ADENINE DEAMINASE 2 (Agrobacteriumfabrum) |
PF01979(Amidohydro_1)PF13382(Adenine_deam_C) | 3 | ASP A 15LEU A 18GLN A 30 | None | 0.77A | 3g4lA-3t8lA:undetectable | 3g4lA-3t8lA:21.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3tgw | V-TYPE ATP SYNTHASEBETA CHAIN (Methanosarcinamazei) |
PF00006(ATP-synt_ab)PF02874(ATP-synt_ab_N) | 3 | ASP A 279LEU A 280GLN A 299 | None | 0.66A | 3g4lA-3tgwA:undetectable | 3g4lA-3tgwA:22.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3tni | CYCLIN-T1 (Homo sapiens) |
PF00134(Cyclin_N) | 3 | ASP B 32LEU B 35GLN B 190 | None | 0.73A | 3g4lA-3tniB:undetectable | 3g4lA-3tniB:21.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3u44 | ATP-DEPENDENTHELICASE/NUCLEASESUBUNIT A (Bacillussubtilis) |
PF00580(UvrD-helicase)PF12705(PDDEXK_1)PF13361(UvrD_C) | 3 | ASP A 298LEU A 301GLN A 895 | None | 0.64A | 3g4lA-3u44A:undetectable | 3g4lA-3u44A:15.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3u7v | BETA-GALACTOSIDASE (Caulobactervibrioides) |
PF02449(Glyco_hydro_42) | 3 | ASP A 315LEU A 316GLN A 365 | None | 0.77A | 3g4lA-3u7vA:undetectable | 3g4lA-3u7vA:19.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3uam | CHITIN BINDINGDOMAIN (Burkholderiapseudomallei) |
PF03067(LPMO_10) | 3 | ASP A 39LEU A 38GLN A 207 | None | 0.75A | 3g4lA-3uamA:undetectable | 3g4lA-3uamA:17.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ui7 | CAMP ANDCAMP-INHIBITED CGMP3',5'-CYCLICPHOSPHODIESTERASE10A (Homo sapiens) |
PF00233(PDEase_I) | 3 | ASP A 674LEU A 675GLN A 726 | ZN A 772 (-2.4A)C1L A 1 (-4.3A)C1L A 1 (-2.9A) | 0.41A | 3g4lA-3ui7A:38.0 | 3g4lA-3ui7A:27.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4d7k | SAM-DEPENDENTMETHYLTRANSFERASES (Streptomycesdavaonensis) |
PF00891(Methyltransf_2) | 3 | ASP A 91LEU A 92GLN A 164 | None | 0.67A | 3g4lA-4d7kA:undetectable | 3g4lA-4d7kA:23.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4dxy | CYTOCHROME P450 (Novosphingobiumaromaticivorans) |
PF00067(p450) | 3 | ASP A 173LEU A 177GLN A 183 | None | 0.77A | 3g4lA-4dxyA:undetectable | 3g4lA-4dxyA:21.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4e2i | LARGE T ANTIGEN (Macaca mulattapolyomavirus 1) |
PF06431(Polyoma_lg_T_C) | 3 | ASP A 283LEU A 345GLN A 519 | None | 0.75A | 3g4lA-4e2iA:undetectable | 3g4lA-4e2iA:23.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4f0j | PROBABLE HYDROLYTICENZYME (Pseudomonasaeruginosa) |
PF00561(Abhydrolase_1) | 3 | ASP A 243LEU A 240GLN A 48 | None | 0.56A | 3g4lA-4f0jA:undetectable | 3g4lA-4f0jA:23.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fkz | UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE (Bacillussubtilis) |
PF02350(Epimerase_2) | 3 | ASP A 47LEU A 46GLN A 68 | NoneNoneUD1 A 401 (-3.9A) | 0.76A | 3g4lA-4fkzA:undetectable | 3g4lA-4fkzA:24.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4gax | AMORPHA-4,11-DIENESYNTHASE (Artemisia annua) |
PF01397(Terpene_synth)PF03936(Terpene_synth_C) | 3 | ASP A 55LEU A 54GLN A 81 | None | 0.79A | 3g4lA-4gaxA:undetectable | 3g4lA-4gaxA:22.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4hl7 | NICOTINATEPHOSPHORIBOSYLTRANSFERASE (Vibrio cholerae) |
PF04095(NAPRTase) | 3 | ASP A 56LEU A 55GLN A 115 | None | 0.77A | 3g4lA-4hl7A:undetectable | 3g4lA-4hl7A:23.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4htz | CGMP-DEPENDENT3',5'-CYCLICPHOSPHODIESTERASE (Homo sapiens) |
PF00233(PDEase_I) | 3 | ASP A 808LEU A 809GLN A 859 | ZN A1001 (-2.5A)NoneNone | 0.45A | 3g4lA-4htzA:38.5 | 3g4lA-4htzA:27.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4igm | 2-AMINO-3-CARBOXYMUCONATE-6-SEMIALDEHYDEDECARBOXYLASE (Homo sapiens) |
PF04909(Amidohydro_2) | 3 | ASP A 99LEU A 96GLN A 142 | None | 0.76A | 3g4lA-4igmA:undetectable | 3g4lA-4igmA:22.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4irn | PROLYL-ACPDEHYDROGENASE ([Oscillatoria]sp. PCC 6506) |
PF00441(Acyl-CoA_dh_1)PF02770(Acyl-CoA_dh_M)PF02771(Acyl-CoA_dh_N) | 3 | ASP A 32LEU A 28GLN A 262 | None | 0.81A | 3g4lA-4irnA:undetectable | 3g4lA-4irnA:18.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4itx | CYSTATHIONINEBETA-LYASE METC (Escherichiacoli) |
PF01053(Cys_Met_Meta_PP) | 3 | ASP A 386LEU A 387GLN A 282 | None | 0.79A | 3g4lA-4itxA:undetectable | 3g4lA-4itxA:22.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4mfi | SN-GLYCEROL-3-PHOSPHATE ABC TRANSPORTERSUBSTRATE-BINDINGPROTEIN USPB (Mycobacteriumtuberculosis) |
PF13416(SBP_bac_8) | 3 | ASP A 204LEU A 205GLN A 381 | None | 0.75A | 3g4lA-4mfiA:undetectable | 3g4lA-4mfiA:23.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4n30 | PROTEIN DISULFIDEISOMERASE (Pseudomonasaeruginosa) |
PF13462(Thioredoxin_4) | 3 | ASP A 145LEU A 144GLN A 115 | None | 0.73A | 3g4lA-4n30A:undetectable | 3g4lA-4n30A:18.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4n3y | RAB GTPASE-BINDINGEFFECTOR PROTEIN 1 (Homo sapiens) |
PF09311(Rab5-bind) | 3 | ASP B 577LEU B 581GLN B 587 | None | 0.81A | 3g4lA-4n3yB:undetectable | 3g4lA-4n3yB:14.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4nfd | PAIREDIMMUNOGLOBULIN-LIKETYPE 2 RECEPTOR BETA (Homo sapiens) |
PF07686(V-set) | 3 | ASP A 89LEU A 117GLN A 7 | None | 0.83A | 3g4lA-4nfdA:undetectable | 3g4lA-4nfdA:14.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4o6d | NS1 (West Nile virus) |
PF00948(Flavi_NS1) | 3 | ASP B 24LEU B 198GLN B 66 | None | 0.77A | 3g4lA-4o6dB:undetectable | 3g4lA-4o6dB:21.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4p7w | L-PROLINECIS-4-HYDROXYLASE (Mesorhizobiumjaponicum) |
PF05118(Asp_Arg_Hydrox)PF05373(Pro_3_hydrox_C) | 3 | ASP A 19LEU A 23GLN A 52 | None | 0.78A | 3g4lA-4p7wA:undetectable | 3g4lA-4p7wA:21.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4pj3 | INTRON-BINDINGPROTEIN AQUARIUS (Homo sapiens) |
PF13086(AAA_11)PF13087(AAA_12)PF16399(Aquarius_N) | 3 | ASP A1269LEU A1299GLN A1136 | None | 0.69A | 3g4lA-4pj3A:undetectable | 3g4lA-4pj3A:14.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4r9x | COPPER HOMEOSTASISPROTEIN CUTC (Bacillusanthracis) |
PF03932(CutC) | 3 | ASP A 106LEU A 107GLN A 81 | CA A 303 (-2.9A)NoneNone | 0.81A | 3g4lA-4r9xA:undetectable | 3g4lA-4r9xA:22.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ru5 | TAILSPIKE GP27 (Pseudomonasphage phi297) |
no annotation | 3 | ASP A 613LEU A 620GLN A 554 | None | 0.76A | 3g4lA-4ru5A:undetectable | 3g4lA-4ru5A:18.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4win | GMP SYNTHETASE (Plasmodiumfalciparum) |
PF00117(GATase) | 3 | ASP A 37LEU A 12GLN A 98 | None | 0.77A | 3g4lA-4winA:undetectable | 3g4lA-4winA:20.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4wzi | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B (Homo sapiens) |
PF00233(PDEase_I) | 3 | ASP A 564LEU A 565GLN A 615 | ZN A 801 (-2.5A)NoneNone | 0.17A | 3g4lA-4wziA:52.2 | 3g4lA-4wziA:47.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xmm | NUCLEOPORIN NUP145 (Saccharomycescerevisiae) |
PF12110(Nup96) | 3 | ASP B 188LEU B 191GLN B 449 | None | 0.71A | 3g4lA-4xmmB:undetectable | 3g4lA-4xmmB:20.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4y0i | 4-AMINOBUTYRATEAMINOTRANSFERASE,MITOCHONDRIAL (Sus scrofa) |
PF00202(Aminotran_3) | 3 | ASP A 393LEU A 394GLN A 400 | None | 0.70A | 3g4lA-4y0iA:undetectable | 3g4lA-4y0iA:20.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4yj1 | UNCHARACTERIZEDPROTEIN (Trypanosomabrucei) |
PF09818(ABC_ATPase) | 3 | ASP A 444LEU A 445GLN A 404 | None | 0.76A | 3g4lA-4yj1A:undetectable | 3g4lA-4yj1A:18.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4yzz | TRAP TRANSPORTERSOLUTE BINDINGPROTEIN (Bordetellabronchiseptica) |
PF03480(DctP) | 3 | ASP A 113LEU A 110GLN A 197 | None | 0.56A | 3g4lA-4yzzA:undetectable | 3g4lA-4yzzA:20.67 |